Stomach Cancer Doctors in Turkey — Page 2

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

The doctor graduated from Ankara University Medical School and completed residency training in internal medicine at Ankara GATA Medical School. Specializing in medical oncology and hematology, the doctor completed a clinical fellowship in the USA. A pioneer in Turkey, the doctor was part of the team that performed the first bone marrow transplantation in the country. The doctor has served as a visiting lecturer at prestigious institutions in London and Switzerland. Holding the European Medical Oncology Certificate, the doctor is a founding member of both The Turkish Society of Medical Oncology and the Turkish Oncology Group. The clinical focus includes breast, gastrointestinal, lung cancers, lymphomas, and myeloma.

Assistant Professor Tahsin Ozadli has managed over 1,100 oncology procedures and specialises in stomach and oesophageal cancer care at Valued Med Hub Hospitals.

• Trained at the Ankara Oncology Training and Research Hospital specialising in medical oncology
• Focuses on gastrointestinal oncology including stomach and oesophageal tumour management
• Performs medical oncology treatments for both routine and stage IV cases
• Active researcher with numerous citations for work in oncological treatment protocols
• Expertise in medical oncology for lung and breast cancer cases

Professor Ozcan Yildiz is a leading medical oncologist at Medipol Mega University Hospital with a decade of documented focus on gastrointestinal cancers.

• Specialises in managing gastroenteropancreatic neuroendocrine tumours and complex digestive tract cancers
• Publishes clinical research in international journals like Medical Oncology on patient survival and treatment outcomes
• Expert in coordinated chemotherapy protocols for stomach and colon cancer cases
• Focuses on evidence-based care including managing paraneoplastic syndromes and treatment side effects

Professor Saban Sec leads specialist care at Valued Med Hub Hospitals, where he focuses on targeted therapies for HER2-positive gastric cancer.

• Specialises in gastrointestinal oncology, including advanced stomach and liver cancer
• Represents specialist physicians on the Turkish Medical Oncology Association
• Researched precision treatments for gastric cancer at leading hospital centres
• Expertise in managing stomach cancer in elderly patients using perioperative FLOT protocols

Professor of oncosurgery and proctology

Professor Turkan Ozturk Topcu sharpened her expertise in gastrointestinal cancers through clinical training at the world-renowned MD Anderson Cancer Centre in the USA.

• Specialises in managing stomach and oesophageal tumours using targeted chemotherapy protocols
• Trained at the Sunnybrook Odette Cancer Centre in Canada for gastrointestinal oncology
• Fellowship at the Moffitt Cancer Centre focusing on complex tumour management
• Member of the medical oncology team at Valued Med Hub Hospitals

Professor Bunyamin Kaplan is a senior radiation oncologist at the Medipol Mega University Hospital – one of Turkey's largest private medical complexes.

• Specialises in precise radiation therapy for gastrointestinal tumours
• Uses advanced imaging to target cancer cells while sparing healthy tissue
• Member of the Turkish Society of Radiation Oncology
• Practices at a JCI-accredited facility known for high standards

Associate Professor Yusuf Acikgoz brings high-level expertise from The Ohio State University to Lokman Hekim University Ankara Hospital. He is a specialist in managing stomach cancer through targeted medical therapies.

• Served as assistant investigator for the CheckMate-649 Phase III trial for stomach cancer
• Completed a medical oncology fellowship at Ohio State University in the United States
• Member of the American Society of Clinical Oncology (ASCO)
• Qualified with the Occupational English Test (OET) for clear patient communication
• Specialised in immuno-oncology following intensive training in Vienna

Associate Professor Tahsin Ozatli is a senior medical oncologist at Istinye University Liv Hospital, specialising in gastrointestinal and stomach cancers.

• Promoted to Associate Professor in 2016 following extensive clinical research and practice
• Served as a specialist at the Ankara Oncology Clinic, a dedicated cancer centre
• Focuses on targeted drug therapies to treat stomach and gastrointestinal tumours
• Member of Istinye University's academic faculty, training the next generation of oncologists

Professor Gul Alco is a leading radiation oncologist at Medipol Hospital who specialises in using targeted radiotherapy to treat abdominal tumours.

• Uses Intensity-Modulated Radiation Therapy (IMRT) – focuses high-dose radiation on tumours while protecting nearby healthy organs
• Holds the title of Professor at Istanbul Medipol University – one of Turkey's top medical training institutions
• Expert in Image-Guided Radiation Therapy (IGRT) – uses real-time imaging to account for organ movement during treatment
• Member of the Turkish Society for Radiation Oncology

Professor Muzaffer Al is a specialist in keyhole surgical techniques for treating gastrointestinal malignancies at Buyuk Anadolu Hospitals.

• Completed specialist oncological cancer surgery training at the prestigious Istanbul University Cerrahpasa Faculty of Medicine
• Uses laparoscopic surgery – a minimally invasive approach that typically leads to smaller scars and shorter hospital stays
• Specialises in laparoscopic antireflux procedures to manage chronic gastric issues
• Trained at Ondokuz Mayis University and farabi Hospital in complex general surgery

Associate Professor Nail Paksoy is a board-certified medical oncologist specialising in advanced treatment protocols for gastrointestinal malignancies at Medipol Bahçelievler University Hospital.

• Specialises in the FLOT chemotherapy regimen for both operable and metastatic stomach cancer cases
• ESMO Board Certified in Medical Oncology, an international mark of excellence in cancer care
• Managed clinical trials for targeted therapies, including NTRK-fusion positive solid tumours
• Extensive research background in peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumours

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Ozden is a dual-specialist in internal medicine and medical oncology at VM Medical Park, providing expert oversight for complex stomach cancer cases.

• Specialises in medical oncology at VM Medical Park Pendik Hospital
• Completed subspecialty training at Kocaeli University – a leading Turkish research institution
• Registered internal medicine specialist with deep expertise in managing systemic health
• Trained at Istanbul University Cerrahpasa Faculty of Medicine in the English medical programme
• Manages chemotherapy and targeted drug protocols for gastrointestinal malignancies

Associate Professor Mustafa Serkan Alemdar is a dual-certified specialist in internal medicine and medical oncology at Medical Park Antalya. He focuses on creating precise systemic treatment plans for abdominal oncology cases.

• Specialised in medical oncology at Akdeniz University – a major clinical research hub
• Previously served at Antalya Training and Research Hospital managing complex oncology lists
• Expert in systemic therapies including targeted treatments for gastrointestinal tumours
• Member of the Turkish Society of Medical Oncology
• Focuses on multidisciplinary care coordination to improve patient survival outcomes

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.